Meghmani Organics Limited share price
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include acetamiprid, alphacypermethrin, bifenthrin, beta cyfluthrin, cyfluthrin, cypermethrin, deltamethrin, dinotefuran, ethiprole, fipronil, flonicamid, flubendiamide, lambdacyhalothrin, permethrin, profenofos, pymetrozine, pyriproxyfen, and spiromesifen. In addition, the company provides herbicides, such as 2,4 D acid, amine, esters and triclopyr; intermediates, including cypermethric acid chloride, lambdac…Read more
Basic MaterialsAgricultural InputsNSE: MOLISIN INE0CT101020
16 Oct 2026, 3:29 PM IST₹59.55▲ 2.70 (4.75%)
- Market Cap₹ 1,514 Cr.
- Current Price₹ 59.55
- High / Low₹ 83 / 37
- Stock P/E23.5
- Book Value₹ 62
- Dividend Yield0.00 %
- ROCE6.5 %
- ROE1.90 %
- Face Value₹ 1.0
More figures (10)
- EPS (TTM)₹ 2.53
- Price / Book0.97
- OPM2.9 %
- Debt / Equity0.47
- Sales growth (3Y)-5.2 %
- Profit growth (3Y)-50.6 %
- Promoter holding50.3 %
- EV / EBITDA10.5
- Beta0.60
- All-time high₹ 153
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| MOL | +1.79% | +27.13% | +12.78% | -7.34% | -26.02% | -8.99% | -12.89% |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- Meghmani Organics Limited is in the Agricultural Inputs industry (Basic Materials), with a market value of ₹1,514 crore.
- It trades at 23.5 times its last 12 months' earnings and 1.0 times book value.
- Revenue grew -5.2% a year over the last 3 years, profit -50.6% a year.
- Return on equity was 1.9% and return on capital employed 6.5% in the latest year.
- Debt was 0.47 times shareholders' equity.
- The share price is 28.6% below its 52-week high and down 26.0% over one year.
- Promoters and insiders hold about 50.3%; institutions about 0.9%.
Pros
AI- Trades at 23.5 times earnings, below its 3-year median of 30.8.
Cons
AI- Return on equity has been low: -1.8% on average over the last 3 years.
- Interest cover is thin: operating earnings are 2.4 times the interest cost.
- Sales growth has been slow: -5.2% a year over the last 3 years.
- Profit growth has been weak: -50.6% a year over the last 3 years.
- Other income makes up 88% of profit before tax.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About Meghmani Organics Limited
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include acetamiprid, alphacypermethrin, bifenthrin, beta cyfluthrin, cyfluthrin, cypermethrin, deltamethrin, dinotefuran, ethiprole, fipronil, flonicamid, flubendiamide, lambdacyhalothrin, permethrin, profenofos, pymetrozine, pyriproxyfen, and spiromesifen. In addition, the company provides herbicides, such as 2,4 D acid, amine, esters and triclopyr; intermediates, including cypermethric acid chloride, lambdacyhalothric acid (TFP Acid), pyrazole, high cis/trans CMAC, meta phenoxy benzaldehyde, and spiromesifen acid. Further, it offers technical and formulations that are used in crop protection, veterinary …
- Employees
- 1,154
- Head office
- Ahmedabad
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| 2,498 | 2,553 | 1,566 | 2,080 | 2,174 | 2,103 | |
| YOY Sales Growth % | 2.17% | -38.64% | 32.78% | 4.53% | ||
| 2,120 | 2,212 | 1,587 | 1,937 | 1,998 | 1,896 | |
| Material Cost % | 58% | 59% | 65% | 61% | 61% | 59% |
| Employee Cost % | 5% | 5% | 7% | 5% | 6% | 7% |
| Other Expenses % | 22% | 22% | 29% | 27% | 25% | 25% |
| Operating Profit | 379 | 341 | -20 | 143 | 176 | 207 |
| OPM % | 15% | 13% | -1% | 7% | 8% | 10% |
| 96 | 96 | 38 | 44 | 96 | 92 | |
| Exceptional items | 6 | 19 | ||||
| Interest | 9 | 66 | 46 | 69 | 92 | 75 |
| Depreciation | 63 | 77 | 92 | 108 | 119 | 119 |
| Profit before tax | 409 | 313 | -121 | 9 | 62 | 105 |
| 26% | 24% | 212% | 54% | 39% | ||
| Current tax | 87 | 79 | 5 | 6 | 36 | |
| Deferred tax | 17 | -4 | -20 | 15 | -3 | |
| 304 | 238 | -106 | -11 | 29 | 64 | |
| Profit from associates | -0 | -0 | ||||
| Profit to shareholders | 304 | 238 | -106 | -11 | 29 | 64 |
| YOY Profit Growth % | -21.91% | -144.60% | ||||
| EPS in Rs | 11.97 | 9.35 | -4.17 | -0.42 | 1.13 | 2.53 |
| Dividend Payout % | 12% | 15% |
Compounded Sales Growth
- 3 Years:
- -5%
- TTM:
- -8%
Compounded Profit Growth
- 3 Years:
- -51%
- TTM:
- 241%
Stock Price CAGR
- 5 Years:
- -13%
- 3 Years:
- -9%
- 1 Year:
- -26%
Return on Equity
- 4 Years:
- 2%
- Last Year:
- 2%
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| 2,494 | 2,557 | 1,540 | 2,004 | 2,092 | 2,022 | |
| YOY Sales Growth % | 2.52% | -39.77% | 30.13% | 4.39% | ||
| 2,115 | 2,193 | 1,530 | 1,824 | 1,863 | 1,780 | |
| Material Cost % | 58% | 59% | 65% | 62% | 61% | 59% |
| Employee Cost % | 5% | 5% | 7% | 5% | 5% | 6% |
| Other Expenses % | 22% | 22% | 28% | 25% | 23% | 23% |
| Operating Profit | 379 | 364 | 9 | 180 | 229 | 242 |
| OPM % | 15% | 14% | 1% | 9% | 11% | 12% |
| 96 | 96 | 43 | 44 | 94 | 88 | |
| Exceptional items | 6 | |||||
| Interest | 9 | 64 | 43 | 53 | 73 | 58 |
| Depreciation | 60 | 68 | 83 | 86 | 87 | 88 |
| Profit before tax | 412 | 327 | -74 | 85 | 162 | 184 |
| 25% | 24% | 22% | 22% | 23% | ||
| Current tax | 87 | 79 | 5 | 6 | 36 | |
| Deferred tax | 18 | -2 | -22 | 13 | 0 | |
| 308 | 250 | -57 | 66 | 125 | 142 | |
| YOY Profit Growth % | -18.70% | -122.59% | 88.59% | |||
| EPS in Rs | 12.11 | 9.85 | -2.22 | 2.61 | 4.93 | 5.60 |
| Dividend Payout % | 12% | 14% |
Compounded Sales Growth
- 3 Years:
- -6%
- TTM:
- -7%
Compounded Profit Growth
- 3 Years:
- -21%
- TTM:
- 26%
Stock Price CAGR
- 5 Years:
- -13%
- 3 Years:
- -9%
- 1 Year:
- -26%
Return on Equity
- 4 Years:
- 2%
- Last Year:
- 2%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 25 |
| Reserves | 1,644 | 1,502 | 1,490 | 1,519 |
| 824 | 837 | 829 | 726 | |
| Long term borrowings | 402 | 383 | 283 | 161 |
| Short term borrowings | 419 | 452 | 546 | 565 |
| 705 | 674 | 741 | 750 | |
| Trade payables | 459 | 511 | 557 | 545 |
| Current liabilities | 1,030 | 1,062 | 1,204 | 1,226 |
| Total Liabilities | 3,198 | 3,039 | 3,085 | 3,021 |
| 1,510 | 1,659 | 1,640 | 1,562 | |
| Gross block | 1,862 | 2,099 | 2,179 | 2,205 |
| Accumulated depreciation | 352 | 440 | 539 | 643 |
| Goodwill & intangibles | 12 | 14 | 17 | 19 |
| CWIP | 346 | 509 | 77 | 79 |
| 1,343 | 871 | 1,368 | 1,380 | |
| Inventories | 652 | 517 | 599 | 529 |
| Trade receivables | 523 | 433 | 567 | 672 |
| Cash & equivalents | 31 | 17 | 23 | 16 |
| Current assets | 1,466 | 1,212 | 1,350 | 1,315 |
| Total Assets | 3,198 | 3,039 | 3,085 | 3,021 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 204 | 250 | 66 | 222 | |
| Profit for the year | 238 | -106 | -11 | 29 |
| Working capital changes | -130 | 245 | -113 | 9 |
| Direct taxes paid | -84 | -7 | -4 | -28 |
| -418 | -178 | 31 | -38 | |
| Fixed assets purchased | -465 | -266 | -89 | -45 |
| Fixed assets sold | 1 | 2 | 3 | 1 |
| Investments purchased | -851 | -244 | -33 | -72 |
| Investments sold | 881 | 315 | 143 | 72 |
| 234 | -85 | -91 | -190 | |
| Proceeds from borrowings | 328 | 157 | 62 | 4 |
| Repayment of borrowings | -74 | -136 | -175 | -156 |
| Interest paid | -42 | -63 | -80 | -87 |
| Dividends paid | -36 | -36 | ||
| Net Cash Flow | 21 | -14 | 6 | -7 |
| Free Cash Flow | -261 | -17 | -23 | 177 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROE | — | 14.2% | -6.6% | -0.7% | 1.9% |
| ROCE | — | 15.1% | -4.3% | 3.0% | 6.5% |
| Operating margin | — | 10.5% | -7.1% | 1.8% | 2.9% |
| Net margin | — | 9.4% | -6.8% | -0.5% | 1.3% |
| Debt / equity | — | 0.49 | 0.55 | 0.55 | 0.47 |
| Current ratio | — | 1.42 | 1.14 | 1.12 | 1.07 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities).
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 48.95%
- FIIs 0.84%
- Government 0.04%
- Public 50.17%
| % | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.32% | 49.32% | 49.32% | 49.33% | 49.33% | 49.41% | 48.98% | 48.98% | 48.98% | 48.95% | 48.95% | 48.95% |
| 1.30% | 1.51% | 1.39% | 2.22% | 1.89% | 1.81% | 1.94% | 1.48% | 1.33% | 1.34% | 0.91% | 0.84% | |
| Foreign portfolio investors (Cat. I) | 1.30% | 1.51% | 1.28% | 1.89% | 1.78% | 1.51% | 1.41% | 1.36% | 1.31% | 1.15% | 0.89% | 0.82% |
| Foreign portfolio investors (Cat. II) | 0.01% | 0.11% | 0.33% | 0.12% | 0.30% | 0.53% | 0.12% | 0.02% | 0.19% | 0.02% | 0.02% | |
| 0.27% | 0.21% | 0.22% | 0.42% | 0.27% | 0.48% | 0.37% | ||||||
| Mutual funds | 0.06% | |||||||||||
| Alternative investment funds | 0.20% | 0.20% | 0.20% | 0.42% | 0.25% | 0.48% | 0.37% | |||||
| Government | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| 49.07% | 48.92% | 49.02% | 47.98% | 48.46% | 48.25% | 48.67% | 49.50% | 49.65% | 49.66% | 50.10% | 50.17% | |
| Retail (up to ₹2 lakh) | 32.56% | 33.54% | 33.64% | 31.52% | 31.72% | 31.57% | 31.00% | 32.00% | 32.21% | 32.33% | 33.46% | 32.87% |
| HNIs (above ₹2 lakh) | 6.26% | 6.20% | 6.09% | 6.53% | 7.01% | 6.33% | 7.29% | 7.19% | 7.08% | 6.96% | 6.66% | 6.81% |
| NRIs | 2.99% | 2.96% | 2.94% | 2.72% | 2.69% | 2.91% | 2.81% | 2.87% | 2.85% | 3.02% | 2.96% | 2.98% |
| Bodies corporate | 4.67% | 3.79% | 3.78% | 4.45% | 4.37% | 4.53% | 4.82% | 4.34% | 4.41% | 4.22% | 3.84% | 4.45% |
| IEPF | 0.07% | 0.07% | 0.08% | 0.08% | 0.09% | 0.09% | 0.09% | 0.11% | 0.11% | 0.10% | 0.10% | 0.11% |
| No. of Shareholders | 1,40,829 | 1,52,703 | 1,46,010 | 1,28,875 | 1,27,392 | 1,26,617 | 1,28,082 | 1,31,853 | 1,35,031 | 1,34,841 | 1,35,999 | 1,32,807 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Documents
Announcements
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Meghmani Organics Limited has informed the Exchange about Reconciliation of share capital audit report under SEBI (Depositories and Participants) Regulations, 2018 for the quarter…13-Oct-2026
- Amalgamation/MergerCertified Copy of the Order passed by the NCLT Ahmedabad Bench.09-Oct-2026
- Amalgamation/MergerPlease find attached intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 for receipt of NCLT order.08-Oct-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Meghmani Organics Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.09.202607-Oct-2026
- Trading WindowMeghmani Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201526-Sep-2026
- Shareholders meetingProceedings and Scrutinizers report of 7th Annual General Meeting held on 08.09.2026.08-Sep-2026
- Copy of Newspaper PublicationMeghmani Organics Limited has informed the Exchange about Copy of Newspaper Publication02-Sep-2026
- Copy of Newspaper PublicationMeghmani Organics Limited has informed the Exchange about Copy of Newspaper Publication for 7th Annual General Meeting and evoting15-Aug-2026
- Shareholders meetingMeghmani Organics Limited has informed the Exchange regarding Notice of AGM to be held on September 08, 202614-Aug-2026
- General UpdatesMeghmani Organics Limited has informed the Exchange about Book Closure and Cut off date of 7th Annual General Meeting of the Company13-Aug-2026
- Copy of Newspaper PublicationMeghmani Organics Limited has informed the Exchange about Copy of Newspaper Publication of Pre Advertisement of Annual General Meeting of the Company.12-Aug-2026
- Copy of Newspaper PublicationMeghmani Organics Limited has informed the Exchange regarding the newspaper publication of the notice for the hearing of the Company s petition for the proposed Scheme of Amalgama…11-Aug-2026
Annual reports
- Financial Year 202614-AUG-2026
- Financial Year 202505-JUN-2025
- Financial Year 2024
- Financial Year 202303-JUN-2023
- Financial Year 2022
- Financial Year 2021
Credit ratings
- Credit RatingMeghmani Organics Limited has informed the Exchange about Credit Rating28-Apr-2026
- Credit Rating- RevisionMeghmani Organics Limited has informed the Exchange about Credit Rating- Revision of subsidiary company15-Apr-2026
- Credit RatingMeghmani Organics Limited has informed the Exchange about Credit Rating27-Feb-2026
Concalls & investor meets
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Schedule of meet22-Sep-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Transcript04-Aug-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Link of Recording30-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Schedule of meet25-Jul-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Transcript19-May-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Link of Recording16-May-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Schedule of Earnings Call to discuss Q4 FY26 financial results13-May-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Schedule of meet05-Mar-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Transcript of Earning Call held on 2 February 202607-Feb-2026
- Analysts/Institutional Investor Meet/Con. Call UpdatesMeghmani Organics Limited has informed the Exchange about Link of Recording02-Feb-2026
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 20 Jun 2023
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Questions about Meghmani Organics Limited
What is the share price of Meghmani Organics Limited today?
Meghmani Organics Limited (MOL) last traded at ₹59.55 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.
What is the market cap of Meghmani Organics Limited?
About ₹1,514 crore at the latest price.
What is the P/E ratio of Meghmani Organics Limited?
About 23.5 times its earnings over the last 12 months.
Is Meghmani Organics Limited a good investment?
We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.
How can I buy Meghmani Organics Limited shares?
You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.
Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).
Talk to us
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Experts are available Mon–Sat, 10 AM – 7 PM
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.